Stroke Patients clinical trials

Explore recruiting stroke patients clinical trials.

Recruiting stroke patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stroke Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Reduction of SystemiC Inflammation after ischemic stroke by intravenous DNase administration (ReSCInD)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

AMASCIS-02. ALOGENIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS IN ISCHEMIC STROKE. A PHASE IIB MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Exploratory, longitudinal study to define changes in muscle, tendon and neural properties after botuline neurotoxin type A (BoNT) treatment of spastic equinovarus in first-ever stroke patients: a pilot study

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

A multicentric, randomized, double-blind, parallel, placebo-controlled phase III study to assess the safety and efficacy of sovateltide in patients with acute cerebral ischemic stroke.

Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stroke Patients trials by city

Stroke Patients in Toronto Stroke Patients in Vancouver Stroke Patients in Montreal Stroke Patients in Calgary Stroke Patients in Edmonton Stroke Patients in Ottawa Stroke Patients in Winnipeg Stroke Patients in Quebec City Stroke Patients in Hamilton Stroke Patients in Kitchener Stroke Patients in London Stroke Patients in Halifax Stroke Patients in New York Stroke Patients in Los Angeles Stroke Patients in Chicago Stroke Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease